Singapore shares rose 0.04 per cent or 1.19 points to 3,207.10 on Monday (Jul 3), amid optimism over US economic data released last Friday. Across the broader market, gainers beat losers 303 to 238 after 1.2 billion shares worth S$1.02 billion changed hands.

US Stocks rose slightly Monday in a shortened session that kicked off the second half of what’s already been a stellar year on Wall Street.The Dow Jones Industrial Average added 10.87 points, or 0.03%, to finish at 34,418.47. The S&P 500 climbed 0.12% to end at 4,455.59, while the Nasdaq Composite advanced 0.21% to 13,816.77.

Top gainers & losers





TEMASEK’s decision to participate in Sembcorp Marine’s (Sembmarine) two rights issues in 2020 and 2021 was made after doing its due diligence into the investment, said Minister in the Prime Minister’s Office Indranee Rajah in Parliament on Monday (Jul 3).

SINGAPORE-BASED crypto company Zipmex has taken legal action against its Thai investor, V Ventures, for allegedly backing out of a US$100 million rescue deal.The deal would have resulted in Zipmex’s creditors, totalling more than 70,000, recovering all their funds. With the plan now unlikely to succeed, the company has proposed a new scheme of arrangement.

OCBC (Hong Kong) expects that a boost to its Asean-Greater China growth plans will add S$3 billion in revenue by 2025, on top of its current growth trajectory. The bank has S$93 billion in total assets in Greater China, in addition to a 20 per cent stake in Bank of Ningbo. Since 2012, it has established Greater China Business Offices across Asean to capture the link between Asean and Greater China.

SINGAPORE’S birth rate hit a record low in 2022, while at the same time the country reached the highest number of total yearly deaths since 1960. Official figures released by the Immigration and Checkpoints Authority (ICA) showed a 7.9 per cent drop in the number of live births, from 38,672 in 2021 to 35,605 in 2022.

SINGAPORE’S overall factory activity improved slightly in June, but remained in contraction territory for the third straight month, as weak global demand continues to hit manufacturing sentiment in the region. The Purchasing Managers’ Index (PMI) inched up 0.2 point to 49.7 last month, contracting at a slower rate than in May, data from the Singapore Institute of Purchasing and Materials Management (SIPMM) showed on Monday (Jul 3).


US MANUFACTURING slumped further in June, reaching levels last seen when the economy was reeling from the initial wave of the Covid-19 pandemic, according to a survey on Monday (Jul 3), which also showed price pressures at the factory gate deflating. The Institute for Supply Management (ISM) said that its manufacturing purchasing managers’ index (PMI) dropped to 46.0 last month, the lowest reading since May 2020, from 46.9 in May. That marked the eighth straight month that the PMI stayed below the 50 threshold, which indicates contraction in manufacturing. It is the longest such stretch since the Great Recession.

UBS has gone on a US recruiting drive for wealth managers catering to rich Americans, even as it considers culling 30 per cent of its combined global workforce after the takeover of Credit Suisse.UBS recruited 50 financial advisers, including from Bank of America’s Merrill Lynch unit, JPMorgan Chase’s recently acquired First Republic Bank, Citigroup and Wells Fargo, in the first half of the year. Of those, 30 came after the Credit Suisse deal was announced in March. The largest was BG Group, a 13-person team that managed US$2.5 billion at Merrill.

TESLA Inc and BYD Co set sales records in the second quarter, widening their lead as the world’s best-selling electric-car makers. Elon Musk-led Tesla delivered 466,140 cars worldwide, beating Wall Street estimates. BYD, China’s top-selling car brand, posted its best quarter, selling 700,244 fully electric and plug-in hybrid vehicles.

OIL prices settled down 1 per cent on Monday (Jun 3) as worries about a slowing global economy and possible US interest-rate hikes outweighed supply cuts announced for August by top exporters Saudi Arabia and Russia. Brent crude futures settled down 1 per cent, or 76 US cents, at US$74.65 a barrel while US West Texas Intermediate crude settled down 1.2 per cent, or 85 US cents, to US$69.79.

Source: SGX Masnet, Bloomberg, Channel NewsAsia, Reuters, CNBC, WSJ, The Business Times, PSR


PSR Stocks Coverage



For more information, please visit:


Upcoming Webinars

Strategy & Stock Picks 3Q23 (US)

Date: 13 July 2023

Time: 7.30pm – 9pm

Register: https://tinyurl.com/5n7cuwtm

Strategy & Stock Picks 3Q23 (SG)

Date: 15 July 2023

Time: 10am – 12pm

Register: https://tinyurl.com/2fsww93d

Guest Presentation by Ohmyhome [NEW]

Date: 20 July 2023

Time: 12pm – 1pm

Register: https://tinyurl.com/52fef7dh

POEMS Podcast:

Research Videos

Weekly Market Outlook: UHReit, SG Property, Tech Analysis, SG Equity 3Q23 Strategy, SG Weekly & More
Date: 3 July 2023
Click here for more on Market Outlook.
Sign up for our webinars here, and be among the first to receive economy and market updates.


Phillip Research in 3 minutes: #29 Keppel Corporation; Initiation
Click here for more on Phillip in 3 mins.

Follow our Socials

Facebook Social Icon Instagram Icon Twitter Social Icon Youtube Social Icon Linkedin Social Icon TikTok Social Icon Spotify Social Icon

Join our Singapore Equity Research Community on POEMS Mobile 3 App for the latest research reports, market updates, insights and more

Click to join!


The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.

Confidentiality Note

This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com